Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Drug & Device News

By ALM Staff | Law Journal Newsletters |
September 25, 2013

Side-Effect of Anti-Baldness Drug: Better Prostate Health

A study of men who took baldness-treatment drug finasteride for many years shows that the medication has a significant side benefit: It appears to reduce by 30% the chance of a man's developing' prostate cancer. Thompson, Ian M. Jr., et. al, “Long-Term Survival of Participants in the Prostate Cancer Prevention Trial,” N Engl J Med 2013; 369:603-610 Aug. 15, 2013DOI: 10.1056/NEJMoa1215932. The connection between finasteride and prostate health is not completely unexpected, as men have been prescribed the drug for years for reducing the size of enlarged prostate glands, athough this off-label use has not been approved by the FDA. The results of this latest study found that 14.9% of men who did not take finasteride developed prostate cancer, while only 10.5% of the group who took the drug were so afflicted. This suggests that men may want to take the medication as a preventive measure, particularly if they are at a higher risk for the cancer, even though the kind of prostate cancer apparently prevented by finasteride use is the low-grade type that is not likely to lead to death. Preventing this type is worthwhile because the damage done to men who are treated for prostate cancer that is not likely to shorten their lives often leaves them impotent and/or incontinent.

GAO Sees Doctors Ordering Treatments for Financial Gain

The Government Accountability Office (GAO) is calling for a requirement that doctors disclose on Medicare claim forms any financial relationships they have with entities to which they refer their patients. This recommendation came after the GAO, focusing on prostate cancer patients and their treatments, found that doctors who have financial interests in radiation service providers or the equipment they use tend to order radiation treatments for their patients more often than do those doctors with no such financial ties. The non-financially interested physicians tended to treat their patients more often using other equally effective methods that might be less expensive for Medicare and for patients, or even with no treatment at all where the risks possibly outweighed the benefits.

'

Federal Jurisdiction and the Amount in Controversy: Ninth Circuit Announces New Standard

The U.S. Court of Appeals for the Ninth Circuit cited to new guidance from the U.S. Supreme Court to make it more difficult for plaintiffs in class action lawsuits to preserve state-court jurisdiction by limiting the amount of damages sought. Rodriguez v. AT&T Mobility Services, 13-56149 (9th Cir. 8/27/13). Pointing to Standard Fire v. Knowles, 133 S. Ct. 1345 (2013), the three-judge panel overruled its own 2007 decision in Lowdermilk v. U.S. Bank National Association by holding that plaintiffs are not “masters of the complaint” who may avoid federal jurisdiction under the Class Action Fairness Act of 2005 (CAFA) by foregoing damages. Although not a pharmaceuticals lawsuit, Justice Richard Clifton's pronouncement of the law will apply equally to such cases: “We hold that Lowdermilk has been effectively overruled, and that the proper burden of proof imposed upon a defendant to establish the amount in controversy is the preponderance of the evidence standard.”

'

Side-Effect of Anti-Baldness Drug: Better Prostate Health

A study of men who took baldness-treatment drug finasteride for many years shows that the medication has a significant side benefit: It appears to reduce by 30% the chance of a man's developing' prostate cancer. Thompson, Ian M. Jr., et. al, “Long-Term Survival of Participants in the Prostate Cancer Prevention Trial,” N Engl J Med 2013; 369:603-610 Aug. 15, 2013DOI: 10.1056/NEJMoa1215932. The connection between finasteride and prostate health is not completely unexpected, as men have been prescribed the drug for years for reducing the size of enlarged prostate glands, athough this off-label use has not been approved by the FDA. The results of this latest study found that 14.9% of men who did not take finasteride developed prostate cancer, while only 10.5% of the group who took the drug were so afflicted. This suggests that men may want to take the medication as a preventive measure, particularly if they are at a higher risk for the cancer, even though the kind of prostate cancer apparently prevented by finasteride use is the low-grade type that is not likely to lead to death. Preventing this type is worthwhile because the damage done to men who are treated for prostate cancer that is not likely to shorten their lives often leaves them impotent and/or incontinent.

GAO Sees Doctors Ordering Treatments for Financial Gain

The Government Accountability Office (GAO) is calling for a requirement that doctors disclose on Medicare claim forms any financial relationships they have with entities to which they refer their patients. This recommendation came after the GAO, focusing on prostate cancer patients and their treatments, found that doctors who have financial interests in radiation service providers or the equipment they use tend to order radiation treatments for their patients more often than do those doctors with no such financial ties. The non-financially interested physicians tended to treat their patients more often using other equally effective methods that might be less expensive for Medicare and for patients, or even with no treatment at all where the risks possibly outweighed the benefits.

'

Federal Jurisdiction and the Amount in Controversy: Ninth Circuit Announces New Standard

The U.S. Court of Appeals for the Ninth Circuit cited to new guidance from the U.S. Supreme Court to make it more difficult for plaintiffs in class action lawsuits to preserve state-court jurisdiction by limiting the amount of damages sought. Rodriguez v. AT&T Mobility Services, 13-56149 (9th Cir. 8/27/13). Pointing to Standard Fire v. Knowles , 133 S. Ct. 1345 (2013), the three-judge panel overruled its own 2007 decision in Lowdermilk v. U.S. Bank National Association by holding that plaintiffs are not “masters of the complaint” who may avoid federal jurisdiction under the Class Action Fairness Act of 2005 (CAFA) by foregoing damages. Although not a pharmaceuticals lawsuit, Justice Richard Clifton's pronouncement of the law will apply equally to such cases: “We hold that Lowdermilk has been effectively overruled, and that the proper burden of proof imposed upon a defendant to establish the amount in controversy is the preponderance of the evidence standard.”

'

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
'Huguenot LLC v. Megalith Capital Group Fund I, L.P.': A Tutorial On Contract Liability for Real Estate Purchasers Image

In June 2024, the First Department decided Huguenot LLC v. Megalith Capital Group Fund I, L.P., which resolved a question of liability for a group of condominium apartment buyers and in so doing, touched on a wide range of issues about how contracts can obligate purchasers of real property.

Strategy vs. Tactics: Two Sides of a Difficult Coin Image

With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.

CoStar Wins Injunction for Breach-of-Contract Damages In CRE Database Access Lawsuit Image

Latham & Watkins helped the largest U.S. commercial real estate research company prevail in a breach-of-contract dispute in District of Columbia federal court.

Fresh Filings Image

Notable recent court filings in entertainment law.

The Power of Your Inner Circle: Turning Friends and Social Contacts Into Business Allies Image

Practical strategies to explore doing business with friends and social contacts in a way that respects relationships and maximizes opportunities.